Completeness Assessment Correspondence to Senores Pharmaceuticals, Inc.

NonrulemakingOtherFDA-2026-P-5611-0006
🔔 Subscribe
Document

Details

The document's own metadata, straight from regulations.gov.

Posted
Jun 3, 2026
Agency
Food and Drug Administration (FDA)
© 2026 Government Context · not affiliated with any U.S. government agencyPrivacyTermsDockets